Table 2.
Spearman Correlation Analysis Between Glutathione S-Transferase P1 1 (GSTP1) and pro–B-Type Natriuretic Peptide (proBNP) and Clinical Variables of Study Patients (rS, Values)
| Covariate | All patients |
EF >42% |
EF ≤42% |
|||
|---|---|---|---|---|---|---|
| GSTP1 | proBNP | GSTP1 | proBNP | GSTP1 | proBNP | |
| GSTP1 ng/mL | – | 0.36, <.0001 | – | 0.34,=.03 | – | 0.087, .29 |
| EF | −0.82, <.0001 | −0.37, <.0001 | −0.20, .05 | −0.24, .41 | −0.64, <.0001 | −0.08, .32 |
| Age (y) | −0.26, <.001 | −0.1, .22 | −0.04, .91 | −0.14, .68 | −0.30, <.001 | −0.15, .021 |
| PCWP (mm Hg) | 0.32, .05 | 0.04, .63 | 0.18, .97 | −0.09, .63 | −0.041, .63 | 0.065, .44 |
| PVR (Wood units) | −0.091, .62 | −0.06, .82 | −0.02, .73 | −0.18, .56 | −0.1, .27 | −0.07, .4 |
| CI (L min−1 m−2) | −0.45, <.001 | −0.21, .41 | −0.03, .68 | 0.14, .81 | −0.05, .63 | 0.15, .14 |
| Creatinine (mg/dL) | −0.13, .11 | 0.12, .14 | 0.073, .83 | 0.52, .10 | 0.24,<.005 | 0.01, .93 |
| LVMI | 0.10, .43 | 0.16, .04 | 0.21, .31 | 0.57, <.0001 | 0.082, .34 | 0.41, <.0001 |
CI, cardiac index; EF, ejection fraction; LVMI, left ventricular mass index; PAP, pulmonary artery pressure; PCWP, pulmonary capillary wedge pressure; PVR, pulmonary vascular resistance.